Literature DB >> 21839648

Immuno-intervention for the induction of transplantation tolerance through mixed chimerism.

David H Sachs1, Megan Sykes, Tatsuo Kawai, A Benedict Cosimi.   

Abstract

The induction of transplantation tolerance could liberate organ transplant recipients from the complications of life-long chronic immunosuppression. The original description of tolerance induction through mixed hematopoietic chimerism in mice utilized lethal whole body irradiation as the preparative regimen for achieving mixed chimerism. While such a regimen might be acceptable for treatment of patients with malignancies, which might also respond to the therapeutic effects of radiation, its toxicity would be unacceptable for patients in need only of an organ transplant. Graft-vs.-host disease, which is frequently a complication of mismatched bone marrow transplantation, would likewise be unacceptable for ordinary clinical transplantation. Therefore, as we have extended the use of this modality for tolerance induction from mice to large animal models, we have attempted to design preparative regimens that avoid both of these complications. In this article, we review our studies of mixed chimerism in mice, miniature swine and monkeys, as well as the results of our recent clinical studies that have extended this treatment modality to a series of kidney transplant patients who have been successfully weaned from all immunosuppression while maintaining stable renal function for up to 8 years.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21839648      PMCID: PMC3178004          DOI: 10.1016/j.smim.2011.07.001

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  75 in total

1.  Intrathymic deletion of alloreactive T cells in mixed bone marrow chimeras prepared with a nonmyeloablative conditioning regimen.

Authors:  J O Manilay; D A Pearson; J J Sergio; K G Swenson; M Sykes
Journal:  Transplantation       Date:  1998-07-15       Impact factor: 4.939

2.  Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance.

Authors:  A Khan; Y Tomita; M Sykes
Journal:  Transplantation       Date:  1996-08-15       Impact factor: 4.939

3.  Preliminary in vitro evidence for regulatory cells in a miniature swine renal allograft model.

Authors:  F L Ierino; K Yamada; T Hatch; D H Sachs
Journal:  Transplant Proc       Date:  1997 Feb-Mar       Impact factor: 1.066

4.  Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.

Authors:  Y Tomita; D H Sachs; A Khan; M Sykes
Journal:  Transplantation       Date:  1996-02-15       Impact factor: 4.939

5.  Mechanism by which additional monoclonal antibody (mAB) injections overcome the requirement for thymic irradiation to achieve mixed chimerism in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.

Authors:  Y Tomita; A Khan; M Sykes
Journal:  Transplantation       Date:  1996-02-15       Impact factor: 4.939

6.  Renal transplantation without immunosuppression in a host with tolerance induced by allogeneic bone marrow transplantation.

Authors:  C Helg; B Chapuis; J F Bolle; P Morel; D Salomon; E Roux; V Antonioli; M Jeannet; M Leski
Journal:  Transplantation       Date:  1994-12-27       Impact factor: 4.939

7.  Marrow engraftment and clinical manifestations of capillary leak syndrome.

Authors:  R A Cahill; T R Spitzer; A Mazumder
Journal:  Bone Marrow Transplant       Date:  1996-07       Impact factor: 5.483

8.  Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys.

Authors:  T Kawai; A B Cosimi; R B Colvin; J Powelson; J Eason; T Kozlowski; M Sykes; R Monroy; M Tanaka; D H Sachs
Journal:  Transplantation       Date:  1995-01-27       Impact factor: 4.939

Review 9.  Outcomes of recipients of both bone marrow and solid organ transplants. A review.

Authors:  B Dey; M Sykes; T R Spitzer
Journal:  Medicine (Baltimore)       Date:  1998-09       Impact factor: 1.889

10.  Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance.

Authors:  T Wekerle; M H Sayegh; J Hill; Y Zhao; A Chandraker; K G Swenson; G Zhao; M Sykes
Journal:  J Exp Med       Date:  1998-06-15       Impact factor: 14.307

View more
  29 in total

1.  Vascularized composite allograft tolerance across MHC barriers in a large animal model.

Authors:  D A Leonard; J M Kurtz; C Mallard; A Albritton; R Duran-Struuck; E A Farkash; R Crepeau; A Matar; B M Horner; M A Randolph; D H Sachs; C A Huang; C L Cetrulo
Journal:  Am J Transplant       Date:  2014-01-09       Impact factor: 8.086

Review 2.  Naturally acquired microchimerism: implications for transplantation outcome and novel methodologies for detection.

Authors:  Michael Eikmans; Astrid G S van Halteren; Koen van Besien; Jon J van Rood; Jos J M Drabbels; Frans H J Claas
Journal:  Chimerism       Date:  2014

Review 3.  What's new in clinical solid organ transplantation by 2013.

Authors:  Maurizio Salvadori; Elisabetta Bertoni
Journal:  World J Transplant       Date:  2014-12-24

Review 4.  Cell therapeutic approaches to immunosuppression after clinical kidney transplantation.

Authors:  Christian Morath; Anita Schmitt; Florian Kälble; Martin Zeier; Michael Schmitt; Flavius Sandra-Petrescu; Gerhard Opelz; Peter Terness; Matthias Schaier; Christian Kleist
Journal:  Pediatr Nephrol       Date:  2017-02-23       Impact factor: 3.714

5.  Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation.

Authors:  Joseph Leventhal; Michael Abecassis; Joshua Miller; Lorenzo Gallon; Kadiyala Ravindra; David J Tollerud; Bradley King; Mary Jane Elliott; Geoffrey Herzig; Roger Herzig; Suzanne T Ildstad
Journal:  Sci Transl Med       Date:  2012-03-07       Impact factor: 17.956

6.  Identification of a colonial chordate histocompatibility gene.

Authors:  Ayelet Voskoboynik; Aaron M Newman; Daniel M Corey; Debashis Sahoo; Dmitry Pushkarev; Norma F Neff; Benedetto Passarelli; Winston Koh; Katherine J Ishizuka; Karla J Palmeri; Ivan K Dimov; Chen Keasar; H Christina Fan; Gary L Mantalas; Rahul Sinha; Lolita Penland; Stephen R Quake; Irving L Weissman
Journal:  Science       Date:  2013-07-26       Impact factor: 47.728

7.  Recombinant anti-monkey CD3 immunotoxin depletes peripheral lymph node T lymphocytes more effectively than rabbit anti-thymocyte globulin in naïve baboons.

Authors:  Isaac Wamala; Abraham J Matar; Evan Farkash; Zhirui Wang; Christene A Huang; David H Sachs
Journal:  Transpl Immunol       Date:  2013-10-22       Impact factor: 1.708

8.  Tolerance induction in HLA disparate living donor kidney transplantation by donor stem cell infusion: durable chimerism predicts outcome.

Authors:  Joseph Leventhal; Michael Abecassis; Joshua Miller; Lorenzo Gallon; David Tollerud; Mary Jane Elliott; Larry D Bozulic; Christopher Houston; Nedjema Sustento-Reodica; Suzanne T Ildstad
Journal:  Transplantation       Date:  2013-01-15       Impact factor: 4.939

Review 9.  Evolving approaches of hematopoietic stem cell-based therapies to induce tolerance to organ transplants: the long road to tolerance.

Authors:  J Leventhal; J Miller; M Abecassis; D J Tollerud; S T Ildstad
Journal:  Clin Pharmacol Ther       Date:  2012-10-10       Impact factor: 6.875

10.  Long-term tolerance to kidney allografts after induced rejection of donor hematopoietic chimerism in a preclinical canine model.

Authors:  Scott S Graves; David W Mathes; George E Georges; Christian S Kuhr; Jeff Chang; Tiffany M Butts; Rainer Storb
Journal:  Transplantation       Date:  2012-09-27       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.